Fingerpaint's acquisition of MedThink will bring extensive medical communications capabilities to Fingerpaint through 2 distinct divisions: MedThink SciCom, which harnesses deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications, and publication groups; and MedThink Communications, which provides medical education and marketing services that influence perception and change the behavior of healthcare professionals to commercial teams of all sizes.
“Adding to our capabilities as our clients’ needs evolve has always been a priority for Fingerpaint,” said Ed Mitzen, founder of Fingerpaint. “Medical communications and education have never been more important than they are now given the ever-changing ways we reach healthcare stakeholders and the growing need to convey increasingly complex science behind many of today’s therapies to ensure people have access to them.”
Ed Mitzen & Scott Goudy
Scott Goudy, president of MedThink, will continue to lead day-to-day operations. “Joining Fingerpaint will accelerate our mission of moving minds, moving markets, and moving medicine by leveraging the company’s capabilities at every step of the commercialization process,” said Goudy.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.